Recruiting Pembrolizumab in Treating Participants With Leukoplakia NCT03603223 Conditions Erythroleukoplakia, Leukoplakia, Neoplasms, +4 more Locations UC San Diego Moores Cancer Center — La Jolla, California, United States USC / Norris Comprehensive Cancer Center — Los Angeles, California, United States UCLA / Jonsson Comprehensive Cancer Center — Los Angeles, California, United States View Trial Details
